Three leading analysts who follow developments within genome editing shared their insights on "GEN Edge Live": Michelle Gilson, a Managing Director with Canaccord Genuity focused on biotechnology; her colleague Arlinda Lee, PhD, a Canaccord Genuity analyst; and Geulah Livshits, PhD, Senior Research Analyst with Chardan covering biotech companies, with a focus on gene editing and oncology.
Joining us on “GEN Edge Live” were: Michelle Gilson, a managing director with Canaccord Genuity focused on biotechnology; her colleague Arlinda Lee, PhD, a Canaccord Genuity analyst; and Geulah Livshits, PhD, senior research analyst with Chardan covering biotech companies, with a focus on gene editing and oncology . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.
